AllDocs -> cancers

Translation Chugai to Support “Pink Ribbon Movement” - a Breast Cancer Awareness Campaign- September 30, 2005 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President Osamu Nagayama (hereinafter, Chugai)] announced today that it would join in the effort for the “Pink Ribbon Movement” 1 incorporated in the “ Breast Cancer Month” campaign starting on October 1 for the purpose of conveying the importance of early detection, early diagnosis and early treatment of breast cancer . Chugai will be a special co-sponsor for a pink ribbon symposium 2 entitled “Pink Ribbon for Your Smile - We Shall Overcome Breast Cancer -“(hosted by The Asahi Shimbun Company, the Japan Cancer Society and others; held at Kobe Portopia Hall on Sunday, October 23 starting at 1 p.m.). Chugai will also co-sponsor the “Pink Ribbon Design Grand Prix” (hosted by The Asahi ...

Senate Approves Continuing Breast Cancer Research Stamp -- $47.4 million raised for breast cancer research to date -- September 28, 2005 Washington, DC – The U.S. Senate today approved legislation sponsored by Senators Dianne Feinstein (D-Calif.) and Kay Bailey Hutchison (R-Texas) that would extend the Breast Cancer Research Stamp for another two years. “ The Breast Cancer Research Stamp is the first stamp of its kind dedicated to raising funds for a special cause and remains just as necessary today as ever ,” Senator Feinstein said. “The money raised with each sale of this exceptional stamp will help save lives until a cure is found. This wonderful stamp has also focused public awareness on a devastating disease and provided hope to breast cancer survivors to help find a cure. I hope that the House will act soon to continue the legacy of the stamp.” “This program ...

Alcohol Consumption and Breast Cancer Hormone Receptors Shelley M. Enger, Ph.D. Research Scientist Kaiser Permanente Medical Care Program Southern California Page 2 Postdoctoral Fellowship at the University of Southern California School of Medicine Funded by the California Breast Cancer Research Program, 1995 - 1997 Page 3 Risk factors for breast cancer Alcohol and breast cancer Breast cancer hormone receptors Alcohol and breast cancer hormone receptors Future research topics Page 4 Breast Cancer Risk Factors Hormonal Genetic Metabolic Other Page 5 ALCOHOL CONSUMPTION Page 6 Over 70 studies to date Significant and direct relationship ...

Optical Transillumination Spectroscopy for Breast Cancer Risk Assessment c Roberta Jong d Brian C Wilson a, b Norman Boyd a, b Kristina Blyschak a a Ontario Cancer Institute 610 University Avenue, Toronto, ON M5G 2M9 b University of Toronto, 610 University Avenue, Toronto . ON M5G 2M9 c Photonics Research Ontario, 60 St George Street, Toronto, ON M5S 1A7 . d Sunnybrook and Women’s Health Science Centre, 2200 Bayview, Toronto, ON M5S 1B2 ABSTRACT – In vivo transillumination spectroscopy is being developed as a means to identify women at risk of developing breast cancer . The first stage in this development is to test whether optical spectroscopy is at least equivalent to X-ray mammographic density as a risk predictor. A prototype instrument ...

Summer 2005 Principal Investigator Esther M. John, Ph.D. Northern California Cancer Center Co-Principal Investigators Dee W. West, Ph.D. Northern California Cancer Center Alice S. Whittemore, Ph.D. Stanford University School of Medicine We have received a number of calls from participants over the past year asking how their personal information is kept safe and secure from identity theft. It is an important question because participants provide detailed information to the Family Registry to help researchers better un- derstand how to prevent and cure cancer . The Family Registry and the Northern California Can- cer Center take the protection of personal infor- mation very seriously and safeguard your personal information in a number of differ- ent ways. These in- clude assigning iden- tification numbers to keep names ...

Johanna Sandahl Swegene Postdoc Programme 2003-09-03 Using Gene Expression Analysis to Elucidate Functional Pathways in Breast Cancer Ingrid Hedenfalk Home Department: Department of Pathology, Malmö University Hospital, Lund University External Lab: Swegene cDNA Microarray Facility, Lund University Doctor's Degree: 2002-03-01, Department of Oncology, Lund University Project Description: Breast cancer is the most frequently diagnosed cancer in women and the second leading cause of cancer death among women in the Western world today. Although considerable progress has been made in the management of breast cancer patients over the past decades, many questions remain to be answered regarding the development of breast cancer . The advent of large- scale analytical methods such as cDNA microarrays for global gene expression profiling and tissue ...

Incidence and Mortality Rate Trends In the United States, breast cancer is the most common non-skin cancer and the second leading cause of cancer -related death in women. Each year, a small number of men also are diagnosed with or die from breast cancer . Although the breast cancer diagnosis rate has increased, there has been a steady drop in the overall breast cancer death rate since the early 1990s. While the incidence rate is lower for African Americans than Whites, the mortality rate is higher. Women of other racial and ethnic groups have lower incidence and mortality rates. It is estimated that approximately $8.1 billion* is spent in the United States each year on treatment of breast cancer . *In 2004 dollars, as reported in Brown ML, Riley GF, Schussler N, and Etzioni RD. Estimating health care costs related to cancer treatment ...

a GAO United States General Accounting Office Report to Congressional Committees September 2003 BREAST CANCER RESEARCH STAMP Effective Fund-Raiser, but Better Reporting and Cost-Recovery Criteria Needed GAO-03-1021 Page 2 Although the U.S. Postal Service (the Service) has not tracked or estimated all costs associated with the BCRS program, it reported that the bulk of BCRS costs, from inception through May 16, 2003, were about $9.5 million. In April 2000, GAO recommended that the Service issue BCRS cost-recovery regulations and make available cost data and analyses to provide postal ratepayers assurance they were not involuntarily subsidizing BCRS costs. The Service issued regulations in July 2000, but it has not yet submitted the recommended data and analyses to Congress. Service officials attributed the ...

BREAST CANCER RESEARCH STAMP Millions Raised for Research, but Better Cost Recovery Criteria Needed United States General Accounting Office GAO Report to Congressional Subcommittees April 2000 GAO/GGD-00-80 Page 2 Page 3 United States General Accounting Office General Government Division Washington, D.C. 20548 Page 1 GAO/GGD-00-80 Breast Cancer Research Stamp B-282358 April 28, 2000 The Honorable Thad Cochran Chairman The Honorable Daniel Akaka Ranking Minority Member Subcommittee on International Security, Proliferation and Federal Services Committee on Governmental Affairs United States Senate The Honorable John M. McHugh Chairman The Honorable Chaka Fattah Ranking Minority Member Subcommittee on the Postal Service, ...

With your help, we can find out more about preventing breast cancer . email: ibis@ cancer .org.uk www.ibis-trials.org To order another copy of this leaflet, please contact the IBIS-2 leaflet request answerphone line on +44 (0) 20 7014 0251. We are looking for female volunteers • aged 40-70, • who have been through the menopause • have a family history of breast cancer or other risk factors to take part in a worldwide research study called IBIS-II (2), to see if a hormone drug, anastrozole, can help prevent breast cancer . IBIS-II International Breast Cancer Intervention Study II We are trying to find out if we can prevent breast cancer . Can you help? had a breast lump that showed atypical ductal or lobular hyperplasia had ductal carcinoma in situ (DCIS) diagnosed in last 6 months ...

breast cancer Breast Cancer Awareness: A Women in Medicine Monthly Focus Jessica Carlsen Reviewed by Kathleen Hecksel AMSA Women in Medicine 2005 Epidemiology 1,2 Breast cancer is the most common cancer among women, after skin cancer . 3 times more common than all gynecologic cancers combined. 1 in 7 women will be diagnosed with invasive breast cancer during their lives, an increase from 1 in 20 in 1960. Approx 211,240 women will be diagnosed with invasive breast cancer in 2005. It is the second leading cause of cancer death among women, after lung cancer . 1 in 33 women who have breast cancer will die. Approx 40,410 women will die from breast cancer in 2005. More than 2 million ...

Chinese Translation done by: Kaili Liang, K.C.Wong; Proofread & Approved by: Patient Relations Department 08/02 Rev 12/02 Welcome Sheet: Having Radiation Therapy For Breast Cancer Welcome Sheet: Having Radiation Therapy For Breast Cancer What is Radiation Therapy For Breast Cancer What Are Some Things I Can Expect at California Pacific Medical Center What Are Some Of The Side Effects I Will Experience Fatigue Page 2 Chinese Translation done by: Kaili Liang, K.C.Wong; Proofread & Approved by: Patient Relations Department 08/02 Rev 12/02 Welcome Sheet: Having Radiation Therapy For Breast Cancer Things you can do to help cope with fatigue include Skin Reaction Here are some things you can do for your skin Page 3 Chinese Translation done by: Kaili Liang, K.C.Wong; Proofread & Approved by: ...

466 July-August 2003 Family Medicine William Huang, MD Feature Editor Forthe Office-based Teacher of Family Medicine (Fam Med 2003;35(7):466-8.) Editor’s Note: In a recent column, John Langlois, MD, noted the increasing role that preceptors will have in teaching learners about genetics (Fam Med 2003;35(5):314-5). In this month’s column, Robert Gramling, MD, and Sean David, MD, SM, of the Brown University Department of Family Medicine give practical information that office-based teachers can share with learners on the role of genetics in assessing a patient’s risk for breast cancer . I welcome your comments about this feature, which is also published on the STFM Web site at www.stfm.org. I also encourage all predoctoral directorsto make copiesof thisfeature anddistribute it to their preceptors (with the appropriate Family Medicine citation). Send your submissions to williamh@bcm.tmc.edu. ...

BREAST CANCER SUPPORT & RESOURCE SERVICES 20 Victoria St., 5 th Floor, Toronto, ON M5C 2N8 1-888-778-3100 Resources for partners of women with breast cancer Breast Cancer Husband: how to help your wife (and yourself) through diagnosis, treatment, and beyond. Marc Silver. Rodale, 2004. One reviewer describes this book as having a “wonderful blend of empathy, humor, and information”. It is like a support group for the men who must face breast cancer with the women they love. It Takes a Worried Man: a Memoir. Brendan Halpin. Random House:Toronto, 2003. This book “brilliantly skewers everyone from medical professionals to family members and details how work, pop music, and movies about flesh-eating zombies helped to save Halpin’s sanity” when his 32-year-old wife was diagnosed with stage four breast cancer . Woman to ...

CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e • N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Inflammatory Breast Cancer Key Points • Inflammatory breast cancer is an uncommon type of breast cancer . • This disease occurs when cancer cells block the lymph vessels in the skin of the breast , causing the breast to become red, swollen, and warm. • Inflammatory breast cancer usually grows rapidly and often spreads to other parts of the body. • Treatment usually starts with chemotherapy, generally followed by surgery and/or radiation. Inflammatory breast cancer is an uncommon type of breast cancer in which breast cancer cells block the lymph vessels in the skin of the breast . This blockage may cause the breast to become red, swollen, and warm. The skin of ...

Health Canada Santé Canada The Issue Breast cancer is one of the most common forms of cancer in women. While the causes of breast cancer are not fully understood, research shows that you can lower your risk of developing the disease or dying from it, by minimizing lifestyle and environmental risk factors and through breast cancer screening. Background The number of breast cancer cases grew slowly from the 1960's to the early 1990's, but leveled off in 1993. One in nine women in Canada will develop breast cancer in her lifetime. In 2003, 21,100 Canadian women will develop the disease, and about 5,300 will die from it. Risks of Developing Breast Cancer Scientific researchers have identified some factors which increase a woman’s risk of breast cancer . Having breast implants to change your breast ...

For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. inflammatory breast cancer What is inflammatory breast cancer ? Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer . It is called inflammatory breast cancer because its main symptoms are swelling and redness of the breast . It is a less common form of invasive ductal cancer . Unlike other forms of breast cancer , IBC often lacks a distinct lump or tumor. Instead, it grows in nests or sheets that spread through the breast . IBC is not usually detected by mammograms or ultrasounds unless there is a defined lump. If no lump is present, it can be hard to diagnose. Because IBC cells spread easily to other ...

For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. breast cancer detection Breast cancer screening methods Mammogram — A mammogram is an X-ray picture of the breast . It is done with a special X-ray machine designed just for this purpose. A mammogram can find many cancers before they can be felt. Find your age on the chart below to see which screening methods you should do and how often you should do them. Clinical breast exam — A breast exam by a health care provider should be part of your regular medical checkup. If it is not, ask for it. A clinical breast exam includes a visual examination and carefully feeling the entire breast and underarm area. If you are 40 or older, ...

For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. breast cancer in men Do men get breast cancer ? Breast cancer in men is rare, but it does happen. After all, men have breast tissue also. The overall ratio of female to male breast cancer in the U.S. is 100 to 1. 1 Although it sounds like a small number, that is still roughly 1,690 men who will be diagnosed, and about 460 who will die of the disease in 2005. 2 The most common symptoms of male breast cancer include a lump in the chest area, skin dimpling or pucking, or nipple changes. Because breast cancer is so much more common in females, many men do not even realize they can develop this disease. Unfortunately, ...

For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. genetics & breast cancer Who has mutations in BRCA1 and BRCA2? The likelihood that you have mutations in the BRCA1 or BRCA2 genes is greater if one or more of the following statements is true for you: you are younger (below age 50) your mother, sister or daughter has had breast cancer before age 50 or ovarian cancer at any age a woman in your family has had both breast cancer and ovarian cancer a woman in your family has had breast cancer in both breasts your family is of Ashkenazi Jewish descent there is male breast cancer in your family Remember, most women who get breast cancer do not have an inherited ...

Related terms Estrogen — A hormone produced primarily by the ovaries that aids in developing female sex organs and in regulating monthly menstrual cycles Hormone — A substance that helps regulate body functions Hormone Therapy (HRT) — Hormone-based drugs given to women to help control the effects of menopause Menopause — The time in a woman’s life when menstrual cycles stop and the level of estrogen in her body decreases Oral Contraceptive — Hormone-based drugs used to prevent pregnancy or help regulate a woman’s menstrual cycle Osteoporosis — A disease in which bones become less dense and may break more easily Progesterone — A hormone that is released by the ovaries during every menstrual cycle and helps prepare a woman’s body for pregnancy Progestin — A synthetic progesterone-like ingredient found in HRT drugs. For more information about ...

For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. if breast cancer returns Facts about recurrence Many recurrences are limited to the breast and can be completely removed by surgery. Nearly one-third of breast cancer recurrences are found by mammography, about half by physical exam and one-fifth by both. 1 That’s why it is so important to get regular screenings after your first diagnosis. About 3 out of 5 women who treat a local recurrence by having a total mastectomy are disease-free 5 years later. 2 Your cancer is less likely to recur if: You had no or few cancerous lymph nodes found during surgery. Your breast cancer was found early and ...

Where to Start Sources of Information on Breast Cancer Suggestions for resources when you begin to look for information about breast cancer . Prepared by the Ninon Bourque Patient Resource Library The Ottawa Hospital Regional Cancer Centre 501 Smyth Road, Ottawa, ON, K1H 8L6 613-737-7700 ext 70107 These resources are provided for information purposes only and are not intended as a substitute for medical care. Inclusion of a resource does not imply endorsement by The Ottawa Hospital. If you have any questions about your healthcare, please consult your healthcare provider. If you would like to have more information about this topic, please contact the Ninon Bourque Patient Resource Library at 613-737-7700 ext. 70107 or consumerhealth@ottawahospital.on.ca . Pamphlet Breast cancer : what you need to know An 8-page booklet providing information about breast ...

Page 2 This publication was prepared by: The Cancer Surveillance Section Cancer Control Branch Division of Chronic Disease and Injury Control California Department of Health Services 1700 Tribute Road, Suite 100 Sacramento, CA 95815-4402 (916) 779-0300 http://www.dhs.ca.gov/cdic or http://www.ccrcal.org Suggested citation: Harris DH,Bates J,Morris CR,Kwong SL,and WrightWE. Female Breast Cancer in California,2005. Sacramento, CA; California Department of Health Services, Cancer Surveillance Section, July 2005. Production and design by Maggie Burgos, California Cancer Registry Copyright information: All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. This and other California Cancer Registry publications are available on the ...

FOR IMMEDIATE RELEASE Contact: Adrienne Lenhoff-Wise (248) 366-0388, Shazaaam! LLC Rebecca Przybycien (313) 833-0715 x 2830, Karmanos Cancer Institute AREA BREAST CANCER PROGRAMS WILL SHARE $760,000 2004 Komen Detroit Race for the Cure® announces grants; Next Race is June 11, 2005 DETROIT, December 6, 2004 – The 2004 Komen Detroit Race for the Cure® has awarded $760,000 in grants to local breast cancer education, screening and treatment programs. The Race contributed an additional $250,300 to the Susan G. Komen Breast Cancer Foundation Award and Research Grant Program. Detroit’s Race, locally presented by the Barbara Ann Karmanos Cancer Institute, took place on June 5, 2004 in midtown Detroit. The Institute also announced that the 2005 Race will be held on June 11. A record 30,000 runners, walkers, donors and volunteers participated in the 2004 race, helping raise more than $1.2 ...

Breast Cancer Breast cancer is the most frequently diagnosed cancer among women (aside from skin cancer ). An estimated 211,240 women will be diagnosed in 2005. When found and treated early before it spreads, the five-year survival rate for breast cancer is 98 percent. PREVENTION • Eat a low-fat diet. • Exercise regularly. • Drugs are available to help prevent breast cancer in women at high risk. RISKS • All men and women • Women more than 50 years old are at higher risk • Women with a family history of breast cancer • Women with inherited abnormal genes • Women who had breast cancer in one breast • Obese women with a sedentary lifestyle SYMPTOMS • A lump, mass or thickening in the breast • Change in the size or shape of a breast • Nipple pain, tenderness or discharge, including bleeding • Nipple ...

BREAST CANCER Life after diagnosis What you need to know, ask and expect What is breast cancer ? Breast cancer is a malignant tumour which starts within the breast tissue. If breast cancer spreads it usually first appears in the lymph nodes in the armpit. Beyond this it tends to go to the bones, liver and lungs and becomes known as metastatic breast cancer . How prevalent is it? Breast cancer is the biggest cancer killer of Australian women. About 10,000 diagnoses are made each year and 2,632 died from it in 1996, including 20 men. The good news is that breast cancer can be detected early when the tumour is quite small through increased awareness, self examination and regular mammograms (the BreastScreen Australia Program offers free mammograms to women 50-69 years). Early breast cancer has a very good prognosis - over 90% will survive. How ...

Update: Missed palpable breast cancers and CBE competencies There is now sufficient medical evidence to advise that every breast cancer screening program conduct proficient clinical breast examinations (CBE’S). A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations. Shen Y, Parmigiani G Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):529-32 > CBE + Mammo Palpable breast cancers are inherently different from nonpalpable breast cancers. Skinner KA, Silberman H, Sposto R, Silverstein MJ. Ann Surg Oncol. 2001 Oct;8(9):705-10 Palpable breast cancers Palpable breast cancer which is mammographically invisible. Rajentheran R, Rao CM, Lim E, Lennard TW . Breast . 2001 Oct;10(5):416-20 . False Negatives The medical findings also report that mammograms ...

Breast cancer is the most commonly diagnosed cancer among women. In most instances, the cause is unknown, but for one in 10 women with breast cancer , an inherited predisposition may be involved. Genetic risk assessment for breast cancer should be considered if an individual: s Has been diagnosed with breast cancer at an early age (younger than 50) s Has been diagnosed with bilateral breast cancer s Has been diagnosed with breast cancer and another cancer , such as ovarian, pancreatic, colon, thyroid, stomach or melanoma s Has family members with any of the above s Has a male relative diagnosed with breast or prostate cancer s Has been diagnosed with breast cancer and is of Ashkenazi Jewish descent Inherited predisposition to breast cancer often occurs ...

Combining Argumentation and Bayesian Nets for Breast Cancer Prognosis Matt Williams * and Jon Williamson † Draft of 18th May 2005 Abstract We present a new framework for combining logic with probability, and demon- strate the application of this framework to breast cancer prognosis. Background knowledge concerning breast cancer prognosis is represented using logical argu- ments. This background knowledge and a database are used to build a Bayesian net that captures the probabilistic relationships amongst the variables. Causal hy- potheses gleaned from the Bayesian net in turn generate new arguments. The Bayesian net can be queried to help decide when one argument attacks another. The Bayesian net is used to perform the prognosis, while the argumentation frame- work is used to provide a qualitative explanation of the prognosis. * Advanced Computation ...